KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Treasury Shares: 2011-2025

Historic Treasury Shares for Neogenomics (NEO) over the last 8 years, with Sep 2025 value amounting to $3.0 million.

  • Neogenomics' Treasury Shares rose 37.05% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 37.05%. This contributed to the annual value of $2.2 million for FY2024, which is 10.30% up from last year.
  • Per Neogenomics' latest filing, its Treasury Shares stood at $3.0 million for Q3 2025, which was down 3.62% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Treasury Shares ranged from a high of $3.5 million in Q1 2025 and a low of $331,982 during Q1 2021.
  • In the last 3 years, Neogenomics' Treasury Shares had a median value of $2.2 million in 2024 and averaged $2.4 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first declined by 13.04% in 2021, then surged by 304.82% in 2022.
  • Neogenomics' Treasury Shares (Quarterly) stood at $851,403 in 2021, then soared by 134.30% to $2.0 million in 2022, then decreased by 1.65% to $2.0 million in 2023, then rose by 10.30% to $2.2 million in 2024, then skyrocketed by 37.05% to $3.0 million in 2025.
  • Its Treasury Shares stands at $3.0 million for Q3 2025, versus $3.1 million for Q2 2025 and $3.5 million for Q1 2025.